Related Experiment Video
Updated: Dec 20, 2025

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP60
Published on: December 7, 2017
TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis
Lu Zhang1, Ji Cao1, Longying Dong2
1Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853.
Abstract:
Precisely controlling the activation of transcription factors is crucial for physiology. After a transcription factor is activated and carries out its transcriptional activity, it also needs to be properly deactivated. Here, we report a deactivation mechanism of HIF-1 and several other oncogenic transcription factors. HIF-1 promotes the transcription of an ADP ribosyltransferase, TiPARP, which serves to deactivate HIF-1. Mechanistically, TiPARP forms distinct nuclear condensates or nuclear bodies in an ADP ribosylation-dependent manner. The TiPARP nuclear bodies recruit both HIF-1α and an E3 ubiquitin ligase HUWE1, which promotes the ubiquitination and degradation of HIF-1α. Similarly, TiPARP promotes the degradation of c-Myc and estrogen receptor. By suppressing HIF-1α and other oncogenic transcription factors, TiPARP exerts strong antitumor effects both in cell culture and in mouse xenograft models. Our work reveals TiPARP as a negative-feedback regulator for multiple oncogenic transcription factors, provides insights into the functions of protein ADP-ribosylation, and suggests activating TiPARP as an anticancer strategy.
Insights
This study reveals TiPARP as a key deactivator for oncogenic transcription factors like HIF-1. Activating TiPARP demonstrates significant antitumor effects, suggesting a novel anticancer strategy.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Transcription factor activity requires precise control, including deactivation.
- Oncogenic transcription factors like HIF-1 play roles in cancer development.
- Mechanisms for deactivating transcription factors are not fully understood.
Purpose of the Study:
- To elucidate the deactivation mechanism of HIF-1 and other oncogenic transcription factors.
- To investigate the role of TiPARP in transcription factor regulation.
- To explore the potential of TiPARP as an anticancer therapeutic target.
Main Methods:
- Investigated the interaction between HIF-1 and TiPARP.
- Utilized cell culture and mouse xenograft models to assess TiPARP's function.
- Examined the role of ADP ribosylation in TiPARP-mediated deactivation.
Main Results:
- HIF-1 promotes the transcription of TiPARP, an ADP ribosyltransferase.
- TiPARP forms nuclear bodies that recruit HIF-1α and the E3 ubiquitin ligase HUWE1.
- TiPARP-mediated degradation of HIF-1α, c-Myc, and estrogen receptor was observed.
- TiPARP demonstrated significant antitumor effects in vitro and in vivo.
Conclusions:
- TiPARP acts as a negative-feedback regulator for multiple oncogenic transcription factors.
- Protein ADP-ribosylation plays a role in transcription factor deactivation.
- Activating TiPARP presents a promising anticancer strategy.
More Related Videos
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Telomeres and Telomerase

